Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2011

View Archived Issues

Merck & Co. reports novel P2X7 receptor antagonists

Combined 96-week data disclosed from ECHO and THRIVE trials of rilpivirine versus efavirenz

Phase IIb data reported from SPRING-1 and VIKING trials of dolutegravir in HIV-1-infected adults

Japanese team describes novel putative biomarker of cognitive impairment in Alzheimer's disease

Phase III AQUIRE trial demonstrates benefits of aliskiren fumarate

Scientists reveal new potential biomarker of Alzheimer's disease

Hutchison MediPharma patents new HGF receptor inhibitors

Novel HIV protease inhibitors prepared by Hetero Research Foundation

Scientists at Novartis disclose novel beta-secretase 1 inhibitors

New GPR119 receptor agonists described by Nippon Chemiphar

Novel tryptase beta inhibitors patented

Chelsea Therapeutics reports on phase II droxidopa study

VaxOnco to sponsor phase I trial of Mayo Clinic cancer vaccine

Sublinox approved in Canada

TH-302 and bevacizumab enter clinical trial in astrocytoma

Almirall submits MAA to EMA for aclidinium bromide

ExonHit advances clinical validation of EHT Dx14

FDA issues safety alert regarding use of linezolid and methylene blue

Bayer Yakuhin launches Kogenate FS with Bio-Set injection 2000 in Japan

Merck & Co. to acquire rights to intravenous vernakalant

GlaxoSmithKline reports promising data from phase III ENABLE-1 study

EMA accepts for review Vanda's MAA for oral iloperidone formulation

Impax Pharmaceuticals fully enrolls ASCEND-PD phase III trial of IPX-066

TM-400 receives FDA orphan drug status

Aastrom reaches agreement with FDA on phase III REVIVE-CLI trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...